Sign In
Buy PACB
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
PacBio's (PACB) Preliminary Q4 Revenues Dampened by Lower Sales
05:29pm, Thursday, 12'th Jan 2023 Zacks Investment Research
PacBio's (PACB) revenue growth in the fourth quarter is likely to have been dampened by the displacement of previously-anticipated Sequel IIe sales.
Why Pacific Biosciences Of California Shares Are Trading Higher Today - Pacific Biosciences (NASDAQ:PACB)
12:47pm, Monday, 09'th Jan 2023
Pacific Biosciences of California (PacBio) PACB shares are trading higher today after the company announced it received orders for 76 Revio systems in the fourth quarter of 2022. The company also issu
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
03:01pm, Thursday, 05'th Jan 2023 Benzinga
Upgrades
For Algonquin Power & Utilities Corp (NYSE:AQN), Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, Algonquin Power showed an EPS of $0.11, compared
Here's Why You Should Retain PacBio (PACB) Stock for Now
05:34pm, Wednesday, 04'th Jan 2023 Zacks Investment Research
PacBio's (PACB) strength in its Sequel system raises optimism about the stock.
Here's Why You Should Retain PacBio (PACB) Stock for Now
02:18pm, Wednesday, 04'th Jan 2023
PacBio's (PACB) strength in its Sequel system raises optimism about the stock.
PacBio to Present at 41st Annual J.P. Morgan Healthcare Conference
04:05pm, Wednesday, 28'th Dec 2022
MENLO PARK, Calif. , Dec. 28, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be participating in t
Pacific Biosciences: New Products Set To Drive Strong Growth And Margin Improvement
06:52pm, Wednesday, 21'st Dec 2022
PacBio has recently introduced new products that are expected to drive strong growth and improve gross margins over the next four to five years. The new products are the materialization of the company
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
10:01am, Wednesday, 16'th Nov 2022 Benzinga
Gainers
Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday.
Tenax Therapeutics, Inc. (NASDAQ: TENX) jumped 45.7% to close at $0.1351 on Tuesday.
Exagen Inc.
Sea, UiPath, J&J Snack Foods And Other Big Gainers From Tuesday
07:33am, Wednesday, 16'th Nov 2022 Benzinga
U.S. stocks closed higher on Tuesday, with the Nasdaq Composite gaining more than 150 points. Here is the list of some big stocks recording gains in the previous session.
4D Molecular Therapeutics, I
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session
06:15pm, Tuesday, 15'th Nov 2022 Benzinga
Gainers
SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split.
Pineapple Energy Inc. (NASDAQ: PEGY) shares jumped 45% to $3.41 after the com
PacBio to Present at Upcoming Investor Conferences
04:05pm, Friday, 11'th Nov 2022
MENLO PARK, Calif. , Nov. 11, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be participating in th
PacBio's (PACB) Q3 Earnings Top Estimates, Revenues Lag
03:00pm, Tuesday, 08'th Nov 2022 Zacks Investment Research
PacBio (PACB) witnesses strength in Service and other revenues, along with robust consumable sales, in the third quarter.
Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates
10:55pm, Monday, 07'th Nov 2022 Zacks Investment Research
Pacific Biosciences (PACB) delivered earnings and revenue surprises of 8.57% and 8.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates
07:35pm, Monday, 07'th Nov 2022
Pacific Biosciences (PACB) delivered earnings and revenue surprises of 8.57% and 8.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Pacific Biosciences of California, Inc. (PACB) Q3 2022 Earnings Call Transcript
06:24pm, Monday, 07'th Nov 2022
Pacific Biosciences of California, Inc. (NASDAQ:PACB ) Q3 2022 Earnings Conference Call November 7, 2022 5:00 PM ET Company Participants Todd Friedman - Director of Investor Relations Christian Henry
